Stem cell therapy is emerging as a potential treatment of osteoarthritis (OA) and chondral defects (CDs). However, there is a great deal of heterogeneity in the literature. The indications for stem cell use, the ideal tissue source, and the preferred outcome measures for stem cell–based treatments have yet to be determined.
Purpose:
To provide clinicians with a comprehensive overview of the entire body of the current human literature investigating the safety and efficacy of intra-articular mesenchymal stem cell (MSC) therapy in all joints.
Methods:
To provide a comprehensive overview of the current literature, all clinical studies investigating the safety and efficacy of intra-articular MSC therapy were included. PubMed, MEDLINE, and Cochrane Library databases were searched for published human clinical trials involving the use of MSCs for the treatment of OA and CDs in all joints. A total of 3867 publications were screened.
Results:
Twenty-eight studies met the criteria to be included in this review. Fourteen studies treating osteoarthritis and 14 studies treating focal chondral defects were included. MSCs originating from bone marrow (13), adipose tissue (12), synovial tissue (2), or peripheral blood (2) were administered to 584 distinct individuals. MSCs were administered into the knee (523 knees), foot/ankle (61), and hip (5). The mean follow-up time was 24.4 months after MSC therapy. All studies reported improvement from baseline in at least 1 clinical outcome measure, and no study reported major adverse events attributable to MSC therapy.
Discussion:
The studies included in this review suggest that intra-articular MSC therapy is safe. While clinical and, in some cases, radiological improvements were reported for both OA and CD trials, the overall quality of the literature was poor, and heterogeneity and lack of reproducibility limit firm conclusions regarding the efficacy of these treatments.
Conclusion:
This review provides strong evidence that autologous intra-articular MSC therapy is safe, with generally positive clinical outcomes.
AicherWKBühringH-JHartMRolauffsBBadkeAKleinG. Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells—potential and pitfalls. Adv Drug Delivery Rev. 2011;63(4-5):342-351.
2.
AkgunIUnluMCErdalOAet al. Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study. Arch Orthop Trauma Surg. 2015;135(2):251-263.
3.
BrookeGRossettiTPelekanosRet al. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. Br J Haematol. 2009;144(4):571-579.
CentenoCJBusseDKisidayJKeohanCFreemanMKarliD. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11(3):343-353.
6.
ChahlaJPiuzziNSMitchellJJet al. Intra-articular cellular therapy for osteoarthritis and focal cartilage defects of the knee: a systematic review of the literature and study quality analysis. J Bone Joint Surg Am. 2016;98(18):1511-1521.
7.
DavatchiFAbdollahiBSMohyeddinMShahramFNikbinB. Mesenchymal stem cell therapy for knee osteoarthritis: preliminary report of four patients. Int J Rheum Dis. 2011;14(2):211-215.
8.
DavatchiFSadeghi AbdollahiBMohyeddinMNikbinB. Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. Int J Rheum Dis. 2016;19(3):219-225.
9.
DominiciMLe BlancKMuellerIet al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.
10.
EmadedinMAghdamiNTaghiyarLet al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med. 2012;15(7):422-428.
11.
EmadedinMGhorbani LiastaniMFazeliRet al. Long-term follow-up of intra-articular injection of autologous mesenchymal stem cells in patients with knee, ankle, or hip osteoarthritis. Arch Iran Med. 2015;18(6):336-344.
12.
HaC-WParkY-BChungJ-YParkY-G. Cartilage repair using composites of human umbilical cord blood-derived mesenchymal stem cells and hyaluronic acid hydrogel in a minipig model. Stem Cells Transl Med. 2015;4(9):1044-1051.
13.
HaleemAMSingergyEl AASabryDet al. The clinical use of human culture–expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects a pilot study and preliminary results. Cartilage. 2010;1(4):253-261.
14.
JoCHLeeYGShinWHet al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014;32(5):1254-1266.
15.
KimY-SChoiY-JSuhD-Set al. Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold?Am J Sports Med. 2015;43(1):176-185.
16.
KimY-SKwonO-RChoiY-JSuhD-SHeoDBKohY-G. Comparative matched-pair analysis of the injection versus implantation of mesenchymal stem cells for knee osteoarthritis. Am J Sports Med. 2015;43(11):2738-2746.
17.
KimY-SLeeHJChoiY-JKimYIKohY-G. Does an injection of a stromal vascular fraction containing adipose-derived mesenchymal stem cells influence the outcomes of marrow stimulation in osteochondral lesions of the talus? A clinical and magnetic resonance imaging study. Am J Sports Med. 2014;42(10):2424-2434.
18.
KimY-SParkEHKimYCKohY-G. Clinical outcomes of mesenchymal stem cell injection with arthroscopic treatment in older patients with osteochondral lesions of the talus. Am J Sports Med. 2013;41(5):1090-1099.
KohY-GChoiY-JKwonO-RKimY-S. Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees. Am J Sports Med. 2014;42(7):1628-1637.
21.
KohY-GChoiY-JKwonS-KKimY-SYeoJ-E. Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2015;23(5):1308-1316.
KohY-GKwonO-RKimY-SChoiY-J. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy. 2014;30(11):1453-1460.
24.
KohY-GKwonO-RKimY-SChoiY-JTakD-H. Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial. Arthroscopy. 2016;32(1):97-109.
25.
KoizumiKEbinaKHartDAet al. Synovial mesenchymal stem cells from osteo- or rheumatoid arthritis joints exhibit good potential for cartilage repair using a scaffold-free tissue engineering approach. Osteoarthritis Cartilage. 2016;24(8):1413-1422.
26.
KurodaRIshidaKMatsumotoTet al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage. 2007;15(2):226-231.
27.
LawrenceRCFelsonDTHelmickCG. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum. 2008;58(1):26-35.
28.
LeeKWangVTChanYHHuiJH. A novel, minimally-invasive technique of cartilage repair in the human knee using arthroscopic microfracture and injections of mesenchymal stem cells and hyaluronic acid: a prospective comparative study on safety and short-term efficacy. Ann Acad Med Singapore. 2012;41(11):511-517.
29.
McIntyreJAJonesIADanilkovichAVangsnessCT. The placenta: applications in orthopaedic sports medicine [published online April1, 2017]. Am J Sports Med. doi:10.1177/0363546517697682.
30.
MeirellesLDSFontesAMCovasDTCaplanAI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20(5-6):419-427.
31.
MithoeferKWilliamsRJWarrenRFet al. The microfracture technique for the treatment of articular cartilage lesions in the knee. J Bone Joint Surg Am. 2005;87(9):1911-1920.
32.
NejadnikHHuiJHFeng ChoongEPTaiB-CLeeEH. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38(6):1110-1116.
33.
OrozcoLMunarASolerRet al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation. 2013;95(12):1535-1541.
34.
OrozcoLMunarASolerRet al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results. Transplantation. 2014;97(11):e66-e68.
35.
PakJChangJ-JLeeJHLeeSH. Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints. BMC Musculoskeletal Disorders. 2013;14(1):337.
36.
PersYMRackwitzLFerreiraRet al. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Transl Med. 2016;5(7):847-856.
37.
ReichenbachSBlankSRutjesAWSet al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum. 2007;57(8):1410-1418.
38.
SaulnierNViguierEPerrier-GroultEet al. Intra-articular administration of xenogeneic neonatal mesenchymal stromal cells early after meniscal injury down-regulates metalloproteinase gene expression in synovium and prevents cartilage degradation in a rabbit model of osteoarthritis. Osteoarthritis Cartilage. 2015;23(1):122-133.
39.
SawKYAnzAMericanSAhmadRS. Articular cartilage regeneration with intra-articular injections of autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy. 2013;29(4):684-694.
40.
SekiyaIMunetaTHorieMKogaH. Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with cartilage defects. Clin Orthop Relat Res. 2015;473(7):2316-2326.
41.
SkowrońskiJRutkaM. Osteochondral lesions of the knee reconstructed with mesenchymal stem cells—results. Ortop Traumatol Rehabil. 2013;15(3):195-204.
42.
StriogaMViswanathanSDarinskasASlabyOMichalekJ. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev. 2012;21(14):2724-2752.
43.
SungHJHongSCYooJHet al. Stemness evaluation of mesenchymal stem cells from placentas according to developmental stage: comparison to those from adult bone marrow. J Korean Med Sci. 2010;25(10):1418-1426.
44.
ThomasRJHourdPCWilliamsDJ. Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. J Biotechnol. 2008;136(3-4):148-155.
45.
VangsnessCTFarrJBoydJDellaeroDTMillsCRLeRoux-WilliamsM. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am. 2014;96(2):90-98.
46.
VegaAMartín-FerreroMADel CantoFet al. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99(8):1681-1690.
47.
WakitaniSNawataMTenshoKOkabeTMachidaHOhgushiH. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tiss Eng Regen Med. 2007;1(1):74-79.
48.
WangS-JYinM-HJiangDet al. The chondrogenic potential of progenitor cells derived from peripheral blood: a systematic review. Stem Cells Dev. 2016;25(16):1195-1207.
49.
WolfstadtJIColeBJOgilvie-HarrisDJViswanathanSChahalJ. Current concepts: the role of mesenchymal stem cells in the management of knee osteoarthritis. Sports Health. 2015;7(1):38-44.
50.
WongKLLeeKBLTaiB-CLawPLeeEHHuiJHP. Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthroscopy. 2013;29(12):2020-2028.
